ASA1-OT10

ASA1-OT10 is an experimental **4-aminosalicylic acid derived salicylanilide oligotuftsin conjugate** reported in the medicinal chemistry literature as part of a targeted anticancer research series. The name denotes an ASA1 small-molecule scaffold linked to the OT10 oligotuftsin carrier peptide, a neuropilin receptor ligand used to enhance cellular uptake and tissue penetration in glioblastoma models. In the available publication context, ASA1-OT10 was evaluated **in vitro** against U87 human glioblastoma cells, where compounds in this series reduced cell viability and were associated with induction of autophagy; however, the exact molecular target and any clinical development sponsor were not established in the source material.